Skip to main content
. 2023 Jul 7;202(3):1067–1083. doi: 10.1007/s12011-023-03742-9

Table 3.

Comparison three studied between the groups according to percentage of positive anti-caspase 3 reaction

Percentage of positive anti-caspase 3 reaction Control (n = 5) Cisplatin treated (n = 5) PRP treated (n = 5) F p
Min.–Max. 2.04–3.17 25.10–32.76 7.70–9.70 319.551* <0.001*
Mean ± SD. 2.49 ± 0.48 29.04 ± 2.84 8.95 ± 0.85
Median 2.43 29.17 9.20
p1 <0.001* <0.001*
p2 <0.001*

SD, standard deviation

F, F for one-way ANOVA test, Pairwise comparison bet. each 2 groups was done using post hoc test (Tukey)

p, p value for comparing between the three studied groups

p1, p value for comparing between control and each other group

p2, p value for comparing between cisplatin treated and PRP treated

*Statistically significant at p ≤ 0.05